BofA analyst Salvator Tiano lowered the firm’s price target on Eastman Chemical (EMN) to $115 from $119 and keeps a Neutral rating on the shares. Though the “base” business is performing largely better than the firm expected, even amid a challenging 2024, the Kingsport methanolysis ramp-up is facing additional complications, says the analyst, who thinks shares continue to be fairly valued based on the base business, with most of the upside tied to the successful deployment of its methanolysis technology at additional sites.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMN:
- Eastman Chemical price target lowered to $110 from $115 at Deutsche Bank
- Eastman Chemical price target lowered to $110 from $118 at Wells Fargo
- Eastman Chemical Reports Strong Q3 2024 Results
- Eastman Chemical price target raised to $113 from $107 at Mizuho
- Eastman Chemical reports Q3 EPS $2.26, consensus $2.14